| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009486 Adenoviral vectors having a protein IX deletion |
| 01/11/2007 | US20070009481 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 01/11/2007 | US20070009480 Low-toxicity, long-circulating human interferon-alpha analogs |
| 01/11/2007 | US20070009479 Methods for treating dermatitis using mutant human IL-4 compositions |
| 01/11/2007 | US20070009478 Pegylated g-csf polypeptides and methods of producing same |
| 01/11/2007 | US20070009477 Methods for rational PEGylation of proteins |
| 01/11/2007 | US20070009476 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 01/11/2007 | US20070009469 Treatment of skin, and wound repair, with thymosin beta 4 |
| 01/11/2007 | US20070009434 Imaging and therapeutic method using monocytes |
| 01/11/2007 | US20070009433 14094, a novel human trypsin family member and uses thereof |
| 01/11/2007 | DE60210297T2 Verwendung von langem pentraxin ptx3 für die behandlung von infertilität bei frauen Use of long pentraxin PTX3 for the treatment of infertility in women |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/11/2007 | DE202006007499U1 Verwendung einer Zusammensetzung, die Plexin-A1-DAP12-Interaktion inhibiert, zur Behandlung von Entzündungs-, Autoimmun- oder Knochenresorptionserkrankungen Use of a composition, the Plexin-A1-DAP12 interaction inhibited for the treatment of inflammatory, autoimmune or bone resorption |
| 01/11/2007 | DE10306085B4 Neue Spleißvariante eines Proteinkinase A-Ankerproteins und Verwendung dieser New splice variant of a protein kinase A anchor protein and use of these |
| 01/11/2007 | DE102005030614A1 Zellfreies Transplantat Cell-free graft |
| 01/11/2007 | CA2617201A1 Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha |
| 01/11/2007 | CA2614084A1 Treatment of tumors |
| 01/11/2007 | CA2614049A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 01/11/2007 | CA2613940A1 Methods for tissue engineering |
| 01/11/2007 | CA2613836A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | CA2613813A1 Protein preparation containing s1-5 |
| 01/11/2007 | CA2613749A1 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/11/2007 | CA2613691A1 Anticoagulation agent and uses thereof |
| 01/11/2007 | CA2613627A1 Kinin antagonists for treating bladder dysfunction |
| 01/11/2007 | CA2613464A1 Treatment of dry eye |
| 01/11/2007 | CA2613322A1 Methods of modulating smyd3 for treatment of cancer |
| 01/11/2007 | CA2612191A1 Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos |
| 01/11/2007 | CA2612162A1 Use of oligonucleotides in steroid refractory or steroid dependent inflammatory conditions |
| 01/11/2007 | CA2611941A1 Composition and method for producing stable amyloid beta oligomers of high molecular weight |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741782A2 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| 01/10/2007 | EP1741781A2 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA) |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741719A1 Epithelial cell growth promoter |
| 01/10/2007 | EP1741718A2 Expression of lipoproteins |
| 01/10/2007 | EP1741447A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741444A1 Kinin antagonists for treating bladder dysfunction |
| 01/10/2007 | EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth |
| 01/10/2007 | EP1741440A1 Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740701A1 Osteogenic growth peptide fusion proteins |
| 01/10/2007 | EP1740614A2 Caspase-2 inhibitors and their biological applications |
| 01/10/2007 | EP1740605A2 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 01/10/2007 | EP1740602A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 01/10/2007 | EP1740601A2 Myosin light chain kinase inhibitors and their use |
| 01/10/2007 | EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides |
| 01/10/2007 | EP1740271A1 A method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern |
| 01/10/2007 | EP1740221A2 Methods and compositions for the treatment of polycystic diseases |
| 01/10/2007 | EP1740220A2 Non-natural ribonuclease conjugates as cytotoxic agents |
| 01/10/2007 | EP1740218A1 Materials for treating vascular leakage in the eye |
| 01/10/2007 | EP1740213A2 Liquid growth hormone formulation |
| 01/10/2007 | EP1740209A2 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 01/10/2007 | EP1740204A1 Medicinal use of alpha-mannosidose |
| 01/10/2007 | EP1740203A1 Polypeptide inducing the secretion of angiopoietin |
| 01/10/2007 | EP1740202A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 01/10/2007 | EP1740201A2 Pharmaceutical compositions comprising interferon-tau |
| 01/10/2007 | EP1740200A1 Il-6 for therapy or prevention of chemotherapy-induced neuropathy |
| 01/10/2007 | EP1740199A1 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy |
| 01/10/2007 | EP1740198A2 Anti-aging effects of substance p |
| 01/10/2007 | EP1740197A1 Therapeutic enzyme formulations and uses thereof |
| 01/10/2007 | EP1740196A1 Compositions and method for alleviating inflammation and oxidative stress in a mammal |
| 01/10/2007 | EP1740190A1 Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro |
| 01/10/2007 | EP1740175A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines |
| 01/10/2007 | EP1740173A1 Azabicyclo-octane inhibitors of iap |
| 01/10/2007 | EP1740154A1 Rapid acting drug delivery compositions |
| 01/10/2007 | EP1523243B1 Milk protein isolate and method for preparing same |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1451300A4 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | EP1313491B1 Bioactive fraction of eurycoma longifolia |
| 01/10/2007 | EP1305051A4 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/10/2007 | EP1301534B1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1228093B1 Improvement of peptide transport by conjugation with bile acids |
| 01/10/2007 | EP1218011B1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 01/10/2007 | EP1176984B1 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP0983084B1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
| 01/10/2007 | EP0949331B1 Established microglia |
| 01/10/2007 | EP0918796B1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 01/10/2007 | EP0911393B1 Peptide having cortistatin or somatostatin activity, process for the production of the same, and use of the same |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | CN1894410A DNA-sequence and recombinant production of group 4 major allergens from cereals |
| 01/10/2007 | CN1894409A Human LXR alpha variants |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894281A Treatment of viral infections |
| 01/10/2007 | CN1894279A 分泌性神经凋亡抑制蛋白 Neuronal apoptosis inhibitory protein secretion |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1894277A Periodic antimicrobial peptides |
| 01/10/2007 | CN1894276A HCV NS3-NS4A protease resistance mutants |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 01/10/2007 | CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 01/10/2007 | CN1894273A Peptide inhibiting angiotensin converting enzyme |